热致液晶乙基纤维素与尼龙－1010共混物的研究

在自制单螺杆小型挤出机上通过熔融共混的办法，制备了不同配比（５／９５—２５／７５）的ＥＣ／Ｎｙｌｏｎ—１０１０共混物．用ＷＡＸＤ、ＤＳＣ、毛细管流变仪、力学性能测试等方法对共混物进行了研究．发现共混后尼龙－１０１０的形态结构有明显改变，其强度、模量都有提高，在高剪切速率下，共混物粘度大大降低．配比为１５８５时，这些性能的改进尤为明显．     

络合滴定法测定钙含量微型实验研究

利用微型滴定法测定含钙制品中的Ca2 含量,并对微型滴定法与常量滴定法的平行测定结果进行了比较。结果两种方法无显著性差异,F检验t检验结果均在允许范围内,相对偏差均小于2.0%,微型滴定法的精度达到常量滴定法测定水平,能满足化学分析要求。     

N-二茂铁甲基丁胺的合成

以二茂铁甲醛和正丁胺为原料,经缩合、还原反应制得N-二茂铁甲基丁胺。采用连续操作的方法,用正交实验确定了反应的最佳条件:二茂铁甲醛10 mmol,n(FcCHO)∶n(n-C4H9NH2)∶n(KBH4)=1.0∶1.4∶1.4;于(65±2)℃缩合反应6 h;于(55±2)℃还原反应8 h,产率可达77.8%。在最佳条件下实验规模放大50倍,收率达80.5%,纯度达99.5%。     

精品课程教材《高分子物理实验》建设的体会——三个及时融入

中国科学技术大学"高分子物理实验"课程是2006年安徽省精品课程,作者结合教学研究和精品课程建设经验,总结出了"三个及时融入"的教材建设理念,本文结合实例对该理念的具体含义进行了阐述.     

凝胶网格沉淀法制备纳米氧化锌的正交实验研究

通过凝胶网格沉淀法制备了纳米氧化锌,并通过正交实验探讨了明胶用量、锌离子浓度、碳酸根离子浓度以及反应物配比等因素对其粒径的影响。实验确定了制备纳米氧化锌的优化工艺条件:明胶用量22%、锌离子浓度0.7mol/L、碳酸根浓度0.7mol/L、反应物配比1/1。采用XRD、IR、TG-DTA、TEM及激光粒度等测试手段对产物进行了表征。结果表明,在优化工艺条件下制得了粒径为40nm的氧化锌。     

微波辐射下双(2-苯并咪唑基)丙烷的合成与结构表征

与传统加热相比较,微波辐射促进的有机合成反应具有加热时间短、节能、产率高、不使用或少使用溶剂而对环境友好和节约成本等优点[1]。苯并咪唑类化合物具有广泛的生物活性而被应用到仿生有机合成、遗传学染色体研究及单层膜合成与形态研究的领域[2～4]。苯并咪唑类化合物的传统合成方法是:在HC1、多聚磷酸(PPA)、H3BO3等酸性催化剂使用下加热回流有机酸与邻苯二胺的混合物,然而反应通常需要较高的压力、温度或较长的时间,副反应多[5]。本研究在微波辐射下,以戊二酸和邻苯二胺为原料、PPA为催化剂合成了双(2-苯并咪唑基)丙烷,用正交试…     

新型甘草次酸异噁唑衍生物的合成

以甘草次酸(脱氧甘草次酸)和3-取代苯基-5-氨甲基-异噁唑为原料, 合成了4种甘草次酸异噁唑衍生物, 通过IR, 1H NMR, 13C NMR及FABMS等方法确定了化合物的结构. 同时用L9(34) 正交试验对酰胺化反应的条件进行优化, 确定了酰化反应的最佳条件.     

呋喃西林水溶液在光和热作用下的稳定性

The influence of both light and heat on the stability of nitrofurazone aqueous solution was studied. Results show that in either heating experiments or the exposure to light at high temperatures, the degradation rate obeyed zero-order kinetics. The total rate constant ktotal caused by both light and heat can be divided into two parts: ktotal =kdark klight, where kdark and klight are the degradation rate constants caused by heat and light, respectively. The klight can be expressed as klight=Alight*exp(-Ea,light/RT)*E, where E is the illuminance of light, and Alight and Ea,light both are experimental constants. The values of these kinetic parameters were determined based on the experiments in the dark and upon exposure to three different light sources. Results show that the values of Alight and Ea, light varied with the light source. To save time, labor, and drugs, exponential heating experiments were employed and compared with the isothermal experiments. Results indicated that kinetic parameters obtained by exponential heating experiments are comparable to those obtained by isothermal experiments either in the dark or upon exposure to light.     

综合创新型实验:乙胺嘧啶合成的设计与教学实践

乙胺嘧啶(商品名:达拉匹林)是一种抗寄生虫药物,改进了合成方法,并设计转化为创新型综合教学实验。从对氯苯乙腈出发,使用丙酸乙酯为酰化试剂,在叔丁醇钾作用下得到烯醇前体。在三甲基氧鎓四氟硼酸盐(Me3O·BF4,Meerwein盐)和碱作用下进行选择性甲基化反应得到烯醇甲醚后,与胍在碱性条件下环化得到最终产物达拉匹林,并通过红外光谱、核磁共振对其结构进行表征。改进后的实验方法具有重现性好、毒性低、操作方便、实验微型化等优点。实验过程中不仅提升了学生的实验技能和科研思维,更提高了学生的创新能力和绿色环保意识。     

The glucocorticoid derivative with the phthalimide group cationic nanocrystal for ophthalmic application: a design space development approach

The glucocorticoid derivative of budesonide with a phthalimide group is a drug candidate to treat inflammatory eye diseases; nevertheless, it presents low water solubility. Drug nanocrystals have been proposed to overcome this hurdle. The development of an innovative ophthalmic anti-inflammatory nanosuspension was performed using a design space approach. We obtained the particle size reduction of this glucocorticoid derivative on a nanometer scale (approximately 165.0 nm), applying wet bead milling on a super reduced scale. The design of experiment supported the optimization of the formula evaluating the parameters that influence reducing the particle size and also allowed determining the design space. Considering the two statistical models developed and the size range obtained, we proposed that the optimized formulation for the glucocorticoid derivative nanosuspension may be 1.0 wt% glucocorticoid derivative and 0.092 wt% cetylpyridinium chloride. This formulation was characterized by the morphological, physical–chemical, and mucoadhesive in vitro test and showed potential for ophthalmic use with reduced frequency of product application, improved efficiency, and safety, which may promote better patient compliance.